2024
Jul.
Maintained Grade A in the Quality Assessment of Genetic Testing Institutions
2023
Nov.
2023 - Company name changed from Theragen Genome Care Co., Ltd. to Genome Care Co., Ltd.
Oct.
Maintained Grade A in the Quality Assessment of Genetic Testing Institutions
Jul.
U.S. patent granted for NIPT service technology.
Intellectual Property Name: METHOD OF DETECTING FETAL CHROMOSOMAL ANEUPLOIDY
Patent No. (Date of Registration): 11710565 (2023-07-25)
Apr.
Launched Xenofind (Chromosomal Analysis of Products of Conception) service.
2022
Feb.
Test laboratory Qualified "A" grade obtained.
Dec.
GenomomAI(NIPT) service launch.
2021
Feb.
Test laboratory Qualified "A" grade obtained.
2020
May.
Cost-Effective Method to Measure Fetal Fraction by Adaptive Multiple Regression Techniques with Optimally Selected Autosomal Chromosome Regions(Paper Published IEEE)
2019
Dec
New-born screening by
research & study MOU
with Big-data center AI team (Sejong University)
Nov.
Liquid Biopsy Cancer Screening research & study
MOU
(Yonsei University Hospital)
Oct.
Genetic Test Laboratory Qualified "A" grade obtained
(upgraded for 2020)
Jun.
Premature birth prediction system development MOU
(Hanlim University Hospital)
Jan.
Moved-in to Newly Integrated Lab & Office
(Gwanggyo Central Biz Tower)
2018
Aug.
NIPT patent 3rd stage approval by KIPO
Jul.
NIPT Tech-Transfer to major hospitals in Korea
(CHA / JEIL Hospitals)
International NIPT patent registered in US
May
GenoBro(PGS) Test Launch
iGenomics genetic test
Licensing-in (ERA,EMMA)
Apr.
1st NGS-PGS Test approval in S.Korea (KCDC)
Jan.
NIPT Tech-Transfer contract in Middle-East countries
2017
May
NIPT patent 2nd stage approval by KIPO
Feb.
GenoMom service contract with PTC in Thailand
2016
Oct.
Published 3rd Clinical Report in SCI-class journal
(BMC Medical Genomics)
Apr.
Published 2nd Clinical Report in SCI-class journal
(BMC Medical Genomics)
NIPT patent registered in KIPO
Jan.
Genetic Test Laboratory approved by KCDC
2015
Nov.
Clinical Laboratory Set-up
Sep.
GenoMom(NIPT) test launch
GenomomTM registered
May
Office move to Gwanggyo
2014
Oct.
Published 1st Clinical Report in SCI-class journal
(PLOS ONE)
2012
Nov.
Company established